These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23469944)

  • 1. Protein markers predict body composition during growth hormone treatment in short prepubertal children.
    Decker R; Andersson B; Nierop AF; Bosaeus I; Dahlgren J; Albertsson-Wikland K; Hellgren G
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):675-82. PubMed ID: 23469944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors.
    Swolin-Eide D; Andersson B; Hellgren G; Magnusson P; Albertsson-Wikland K
    Bone; 2018 Nov; 116():144-153. PubMed ID: 30071306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic outcome of GH treatment in prepubertal short children with and without classical GH deficiency.
    Decker R; Albertsson-Wikland K; Kriström B; Nierop AF; Gustafsson J; Bosaeus I; Fors H; Hochberg Z; Dahlgren J
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):346-54. PubMed ID: 20455890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid patterns in treated growth hormone deficient children vs. short stature controls.
    Foster C; Burton A; Scholl J; Scott ML; Gunter V; McCormick K
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):909-14. PubMed ID: 24859507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities.
    Matsuoka H; Fors H; Bosaeus I; Rosberg S; Albertsson-Wikland K; Bjarnason R
    Eur J Endocrinol; 1999 Jan; 140(1):35-42. PubMed ID: 10037249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects.
    Kuromaru R; Kohno H; Ueyama N; Hassan HM; Honda S; Hara T
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3890-6. PubMed ID: 9814464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium supplementation increases bone mass in GH-deficient prepubertal children during GH replacement.
    Zamboni G; Antoniazzi F; Lauriola S; Bertoldo F; Tatò L
    Horm Res; 2006; 65(5):223-30. PubMed ID: 16569932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.
    Andersson B; Hellgren G; Nierop AF; Hochberg Z; Albertsson-Wikland K
    Proteome Sci; 2009 Nov; 7():40. PubMed ID: 19883510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.
    Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD
    Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soft tissue changes in adults with acquired growth hormone deficiency during substitution treatment. A double-blind, randomized, placebo-controlled study after a year of treatment].
    Hansen TB; Vahl N; Jørgensen JO; Christiansen JS; Hagen C
    Ugeskr Laeger; 1997 Jul; 159(28):4394-9. PubMed ID: 9235736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height.
    Modesto Mde J; Amer NM; Erichsen O; Hernandez S; dos Santos CD; de Carvalho JÂ; Pereira RM; França SN; De Lacerda L
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):813-20. PubMed ID: 24756044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.